Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

1-Cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea

EU orphan designation number: EU/3/09/693   
Active ingredient: 1-Cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea
Indication: Treatment of acute myeloid leukaemia
Sponsor: Astex Therapeutics Limited
436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/12/2009 Centralised Orphan - Designation EMEA/OD/091/09 (2009)9601 of 26/11/2009